Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.4 USD | -0.09% | +0.75% | +122.68% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Fusion Pharmaceuticals : Wedbush Trims Price Target on Fusion Pharmaceuticals to $21 From $24, Citing Cost of Capital; Outperform Rating Kept